Wasatch Advisors’s Aceragen Inc ACGN Stock Holding History

Wasatch Advisors’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,070	Closed	-$767K	–	306
2018 Q1	$767K	Buy	+3,070	New	+$842K	0.01%	261

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors's ACGN Position: Q2 2018 in Review

Wasatch Advisors sold out of Aceragen Inc (ACGN) in Q2 2018, closing a stake of 3,070 shares — an estimated $767K sold.

Wasatch Advisors first reported a position in ACGN in Q1 2018 and held it in 1 quarter. The position peaked at $767K in Q1 2018. 93 funds tracked by Wall St. Rank hold ACGN as of Q2 2018.

Wasatch Advisors reported no remaining Aceragen Inc position as of Q2 2018 after selling out during the quarter.
Wasatch Advisors sold 3,070 Aceragen Inc shares in Q2 2018, an estimated $767K.
Wasatch Advisors first reported a position in Aceragen Inc in Q1 2018 and held it in 1 quarter.
Wasatch Advisors's Aceragen Inc position peaked at $767K in Q1 2018.
93 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2018.

Based on Wasatch Advisors's 13F filing for Q2 2018, filed 2 Aug 2018.